for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Shandong Lukang Pharmaceutical Co., Ltd

600789.SS

Latest Trade

6.25CNY

Change

-0.02(-0.32%)

Volume

9,009,187

Today's Range

6.24

 - 

6.33

52 Week Range

5.54

 - 

9.88

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
6.27
Open
6.27
Volume
9,009,187
3M AVG Volume
340.55
Today's High
6.33
Today's Low
6.24
52 Week High
9.88
52 Week Low
5.54
Shares Out (MIL)
880.23
Market Cap (MIL)
5,519.04
Forward P/E
--
Dividend (Yield %)
0.49

Next Event

Q3 2019 Shandong Lukang Pharmaceutical Co Ltd Earnings Release

Latest Developments

More

Shandong Lukang Pharmaceutical to pay A shares div for FY 2017 on July 10

Shandong Lukang Pharmaceutical sees FY 2017 net profit up 292.10 pct to 309.28 pct

Shandong Lukang Pharmaceutical sets up health science and tech JV

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Shandong Lukang Pharmaceutical Co., Ltd

Shandong Lukang Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, manufacture and distribution of pharmaceutical products. The Company's primary products include pharmaceutical preparation products, semi-synthetic antibiotic raw materials, veterinary antibiotics and antibiotic raw materials and others. The Company is also involved in the production and distribution of pharmaceutical intermediates. The Company distributes its products in domestic and overseas markets.

Industry

Biotechnology & Drugs

Contact Info

No. 173, Taibai Building West Road

+86.537.2983174

http://www.lkpc.com

Executive Leadership

Xin Peng

Chairman of the Board, General Manager

Li Li

Chief Financial Officer, Finance Director

Songqiang Liu

Deputy General Manager, Director

Junting Yan

Deputy General Manager, Director

Jie Zhang

Deputy General Manager, Director

Key Stats

Price To Earnings (TTM)
45.61
Price To Sales (TTM)
1.53
Price To Book (MRQ)
1.85
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
85.77
LT Debt To Equity (MRQ)
29.07
Return on Investment (TTM)
2.99
Return on Equity (TTM)
1.86

Latest News

Latest News

BRIEF-Shandong Lukang Pharmaceutical sets up health science and tech JV

* Says it set up a Beijing-based health science and technology JV with partners, with registered capital of 66.7 million yuan

BRIEF-Shandong Lukang Pharmaceutical to set up medical tech R&D JV with partners

* Says co plans to set up a medical tech R&D JV with partners

BRIEF-Shandong Lukang Pharmaceutical receives GMP certificate

* Says it received goods manufacture practice (GMP) certificate from Shandong Food and Drug Administration

BRIEF-Lukang Pharma plans to raise up to 1.1 bln yuan in share private placement to fund projects

* Says it plans to raise up to 1.06 billion yuan ($153.70 million) in private placement of shares to fund projects

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up